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The long-standing argument that focused operations outperform others stands in contrast to claims
about the benefits of broader operational scope. The performance benefits of focus are typically attributed
to reduced complexity, lower uncertainty, and the development of specialized expertise, while the
benefits of greater breadth are linked to the economies of scope achieved by sharing common resources,
such as advertising or production capacity, across activities. Within the literature on corporate strategy,
this tension between focus and breadth is reconciled by the concept of related diversification (i.e.,
a firm with multiple operating units, each specializing in distinct but related activities). We consider
whether there are similar benefits to related diversification within an operating unit and examine the
mechanism that generates these benefits. Using the empirical context of cardiovascular care within
hospitals, we first examine the relationship between a hospital’s level of specialization in cardiovascular
care and the quality of its clinical performance on cardiovascular patients. We find that, on average,
focus has a positive effect on quality performance. We then distinguish between positive spillovers
and complementarities to examine: (1) the extent to which a hospital’s specialization in areas related
to cardiovascular care directly impacts performance on cardiovascular patients (positive spillovers)
and (2) whether the marginal benefit of a hospital’s focus in cardiovascular care depends on the degree
to which the hospital “co-specializes” in related areas (complementarities). In our setting, we find
evidence of such complementarities in specialization.
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A key tension facing many firms concerns the optimal scope of their operations. The benefits of 
operational specialization, or focus, in terms of lower cost or higher quality are widely discussed in both 
manufacturing (Skinner, 1974) and service (Heskett, 1986) settings. Leveraging operational focus has 
been offered as a rationale for decisions ranging from the use of contract manufacturers by consumer 
electronics companies to the use of a single type of aircraft by low-cost airlines or the dedication of an 
entire hospital to patients undergoing a single surgical procedure. In fact, the “law of factory focus” has 
been cited as a key component of received wisdom in the field of operations management (Schmenner 
and Swink, 1998). Despite this broad support for operational focus, some observers have noted that 
seemingly unfocused operations perform at a high level (Ketokivi and Jokinen, 2006) and that a broader 
range of activities may, in fact, increase firm value (Teece, 1980; Panzar and Willig, 1981; Teece et al., 
1994; Villalonga, 2004).  
Some reconciliation of these views may be found in the concept of related diversification, which 
argues that expanding scope into related businesses increases firm value while broader diversification 
into unrelated businesses may reduce it (Rumelt, 1974). The implicit assumption in this literature is that 
related diversification yields a firm with multiple operating units—each specializing in a distinct set of 
activities—and that the specialties of these units are related to each other. In this paper, we consider 
whether the benefits of related diversification also exist within operating units themselves.
1 Specifically, 
we ask whether a focused operating unit can be “too focused”. To the extent that there are benefits to 
related diversification within an operating unit, we offer an empirical approach for identifying the source 
of those benefits.  
Studies of related diversification at the corporate level tend to attribute the benefits of 
diversification to economies of scope, which Panzar and Willig (1981) define as occurring when “…it is 
less costly to combine two or more product lines in one firm than to produce them separately.”  
Economies of scope, however, may emerge from two sources that we aim to isolate in this study: positive 
                                                 
1 Schilling et al. (2003), Boh et al. (2007), and Narayanan et al. (2009) consider whether there are benefits to 
engaging in related activities at the level of small groups and individuals. We discuss this work in greater detail 
below.   3
spillovers and complementarities. Roberts (2004) defines these concepts by noting, “…complementarity 
is conceptually different from a positive spillover. A positive spillover occurs when the overall benefit 
from some activity (rather than the returns to increasing the activity) is increasing in the level of the other 
activity.” (p. 73) Because of our interest in the effects of focus, our study tests for the presence of positive 
spillovers and complementarities based not on an operating unit’s absolute level of specific activities but 
on its level of specialization in those activities. Despite this difference, the conceptual definitions and 
intuition provided by Roberts carry through to our setting. 
A common type of positive spillover is what Markides and Williamson (1994) refer to 
synonymously as the “asset amortization” or “static economies of scope” benefit of related 
diversification. That is, positive spillovers may simply be economies of scale that exist across different 
activities rather than within a single activity. Such economies may appear as either reductions in average 
cost (due to the amortization of fixed investments) or improvements in average quality (due to leveraging 
intangible assets, such as know-how). In either case, a positive spillover occurs when increased 
specialization in a related business segment has a direct benefit on operational performance in a focal 
business segment that is independent of the operating unit’s level of specialization in the focal segment.  
Complementarities, on the other hand, exist if increased specialization in a related business 
segment has an indirect benefit on operational performance in a focal business segment by increasing the 
marginal benefit of specializing more in the focal activity (Milgrom and Roberts 1990, 1994, and 1995). 
Complementarity thus implies that the benefits of related diversification may not be simply due to sharing 
fixed assets but also to the fact that a related activity improves performance of the focal activity at the 
margin. In other words, complementarity suggests a positive interdependence between levels of 
specialization in focal and related activities. 
To clarify further the distinction between these two sources of scope economies, we turn to an 
example from the setting we examine in this study—hospitals. Consider a hospital that only treats 
cardiovascular patients but faces declining demand for cardiovascular services. In the interest of 
amortizing fixed investments that it has made in assets such as hospital beds, operating rooms, and   4
diagnostic services (e.g., radiology), the hospital may decide to add other clinical service lines outside of 
cardiovascular care (e.g., endocrinology or respiratory medicine). To the extent that these other service 
lines directly improve the quality—or reduce the cost—of treating cardiovascular patients regardless of 
the hospital’s level of specialization in cardiovascular care, they exert a positive spillover on 
cardiovascular care. For example, adding these new clinical services to a cardiovascular hospital may 
bring clinicians with general knowledge that can directly benefit the hospital’s performance on 
cardiovascular patients (e.g., a new approach to reducing the rate of hospital-acquired infections that 
benefits many types of patients, including those with cardiovascular disease).  
On the other hand, the addition of clinical specialists in these new service lines would exert a 
complementarity with respect to cardiovascular care to the extent that they give cardiovascular specialists 
access to new sources of knowledge and insight about related conditions (e.g., many patients with 
cardiovascular illness suffer from diabetes, a key area of focus for endocrinologists).  This knowledge 
may help cardiovascular specialists interpret and encode their own specialized experiences with 
cardiovascular patients (Levitt and March, 1988). The increased individual and organizational attention 
(Ocasio, 1997) on these new service lines is likely to provide the context for greater formal and informal 
interaction among clinicians in related specialties (e.g., the “curbside consultations” described extensively 
in the medical literature (Manian and Janssen, 1996; Kuo, et al., 1998; Bergus, et al., 2000)). To the 
extent that the presence of new service lines increases the performance associated with any given level of 
cardiovascular specialization, those services exert a complementarity with respect to cardiovascular care. 
In such cases, there are benefits to “co-specialization” in cardiovascular care and the new service lines.  
The empirical literature on the impact of focus on performance has considered a range of 
performance measures including cost, productivity, customer satisfaction, and quality. In our context, a 
critical measure of performance—and that for which we have reliable information—is quality 
performance. Consistent with prior work examining focus in health care settings, we begin our inquiry by 
asking whether an operating unit that is more focused on a given activity achieves higher quality 
performance (i.e., higher output quality) with respect to that activity than a less-focused unit engaged in   5
the same activity (e.g., Cram et al., 2005; Young et al., 2005; Greenwald et al., 2006; Kc and Terwiesch, 
2009). We continue by testing for the benefits of related diversification; that is, whether the composition 
of a unit's other activities (i.e., outside of the focal area) impacts quality performance in the focal area. In 
so doing, we contribute to the literature on specialization and related diversification by separately 
measuring the extent of positive spillovers and complementarities. This latter line of inquiry allows us to 
examine whether and how the benefits of focusing on a particular activity depend on the degree to which 
an organization is also relatively specialized (i.e., “co-specialized”) in related activities. 
We consider these issues by examining the delivery of cardiovascular care within hospitals. We 
recognize that a hospital can be characterized as either an operating unit or a multi-unit firm.  
Nevertheless, as circumscribed facilities, most hospitals can be viewed as operating units, akin to plants in 
the manufacturing context.  We have chosen our empirical setting for several reasons.  First, hospitals 
tend to provide services across a range of clinical areas (i.e., business segments) such as cardiovascular 
care, cancer, orthopedics, and obstetrics. These segments appear in different proportions and 
combinations across facilities.  For example, a given hospital may devote a substantial share of resources 
to cardiovascular care while allocating comparatively less attention or fewer resources to obstetrics.  
Conversely, another hospital may be characterized by a significant focus in obstetrics with relatively little 
cardiovascular care.   
Second, hospital discharge data includes information on every patient in a particular hospital. 
This characteristic of the data allows us to measure the degree to which a given hospital focuses on a 
clinical area (e.g., cardiovascular services) as a continuous variable based on the percentage of its total 
operational activity dedicated to that clinical area.
2 This continuity is particularly useful in testing for 
complementarities based on the degree to which the marginal benefit of a given level of focus in one 
business segment increases as the share of activity devoted to related segments increases. Third, there are 
                                                 
2 Measuring focus as a continuous, rather than discrete, variable implies that an operating unit need not be dedicated 
solely to one activity (or set of activities) to be considered “focused”. For example, a unit that is 40% dedicated to a 
particular activity—with no other activity accounting for a similarly large portion of the unit’s effort—is relatively 
focused on the first activity.   6
clear and objective measures of quality performance, specifically a hospital’s risk-adjusted mortality rate 
for cardiovascular patients. 
Finally, specialization is particularly relevant in the hospital industry, where many observers have 
noted the value of delivering health care through organizations focused around the needs of patients with 
specific diseases (Herzlinger, 1997; Porter and Teisberg, 2006, 2007; Christensen et al., 2009). In fact, the 
rise of single-specialty hospitals—a large portion of which focus on cardiovascular care—has led to 
significant debate over the value of such facilities. This debate centers on whether such facilities 
outperform traditional “general” hospitals (Herzlinger, 1997, 2000; Dwyer, 2000; Ginsburg, 2000). 
Consistent with the spirited nature of this debate, the empirical studies on this topic offer mixed findings 
(Cram et al., 2005; Schneider et al., 2005; Young et al., 2005; Greenwald et al., 2006; Barro et al., 2006; 
Hwang et al., 2007; Nallamothu et al., 2007; Carey et al., 2008; Hyer et al., 2009; Kc and Terwiesch, 
2009). Overall, this stream of literature highlights the importance of determining how hospitals should 
balance specializing in a single clinical area with building expertise in other areas. 
 
Theory and Hypotheses 
 
The idea that specialization, or focus, improves performance by reducing complexity and 
leveraging task repetition dates back to Smith’s (1776) example of the pin factory and is later captured in 
the work of Fayol (1916) and Taylor (1911). Though containing implications for operating units or entire 
organizations, these early arguments largely center on the performance of the individual worker. March 
and Simon (1958) note that lessons learned about individual specialization may not simply translate to a 
higher level of organization. Nevertheless, subsequent thinking about focus at the level of the operating 
unit (e.g., Skinner’s (1974) concept of the focused factory) is consistent with earlier work on specialized 
labor.   
Several studies provide empirical support for the benefits of focus in the context of manufacturing 
(Hayes and Wheelwright, 1984; Brush and Karnani, 1996; Bozarth and Edwards, 1997; Fisher and Ittner, 
1999; Vokurka and Davis, 2000; Anderson, 2001). Studies in service settings likewise support the   7
benefits of focus at some level (Heskett, 1986; Johnston, 1996; Lapre and Tsikriktsis, 2006; Tsikriktsis, 
2007; Huckman and Zinner, 2008).  Specific to the hospital context, Herzlinger (1997) identifies the 
benefits of applying Skinner’s focused factory to health care delivery. Subsequent studies in the hospital 
industry find benefits of focus in terms of clinical outcomes (e.g., Greenwald et al., 2006) and financial 
performance (e.g., Hyer et al., 2009).  
  Nevertheless, support for the benefits of focus at the level of the operating unit is not unanimous.
3 
Mukherjee et al. (2000) suggest that the impact of reducing focus depends on a manufacturing line’s 
degree of absorptive capacity (Cohen and Levinthal, 1990) with respect to changes in manufacturing 
tasks. In their study of automobile assembly plants, MacDuffie et al. (1996) find that a more complex mix 
of parts negatively affects productivity while a more complex mix of models has no such effect. Further, 
the negative impact of parts complexity can be offset by the adoption of lean management principles. 
Other studies in manufacturing contexts suggest that more-focused operations perform no better than their 
less-focused counterparts (Kekre and Srinivasan, 1990; Suarez et al., 1996; Ketokivi and Jokinen, 2006). 
In the financial services industry, Siggelkow (2003) finds that mutual fund providers with a broader range 
of funds (i.e., less-focused providers) have higher cash inflows than more-focused providers despite the 
fact that the specific funds managed by the latter outperform similar funds managed by the former.  
Finally, a few studies in the hospital industry find that hospitals that devote a majority of their activity and 
resources to cardiovascular patients perform at best no better in terms of patient outcomes on 
cardiovascular procedures (Young et al., 2005; Cram et al., 2005; Kc and Terwiesch, 2009).   
Despite the mixed results highlighted above, the bulk of the empirical literature suggests a 
positive-to-neutral effect of focus on performance. We thus offer the following baseline hypothesis 
related to an operating unit’s level of focus (i.e., specialization in a focal business segment): 
 
                                                 
3 Even at the level of the individual, support for the benefits of specialization is not unanimous. Recent work by Boh 
et al. (2007) and Narayanan et al. (2009) both highlight benefits to some degree of variety in individual work within 
software development contexts.    8
Hypothesis 1: Increasing an operating unit’s level of specialization in a focal business segment improves 
quality performance in that segment. 
 
As noted earlier, several studies at the firm level have argued that increased scope, or 
diversification, may represent an efficient approach to corporate organization (Teece, 1980; Panzar and 
Willig, 1981). Nevertheless, like the previously noted literature on focus at the plant or operating-unit 
level, this firm-level literature offers mixed evidence regarding the impact of diversification on firm value 
(Rhoades, 1974; Lang and Stulz, 1994; Berger and Ofek, 1995; Servaes, 1996; Campa and Kedia, 2002; 
Villalonga, 2004). The literature on related diversification provides insight into these conflicting results 
by striking a balance between claims about the benefits of focus on one hand and those of diversification 
on the other. Rumelt (1974) finds the highest levels of profitability among firms that diversify into areas 
that draw on some “common core skill or resource.” Subsequent work is consistent with this finding and 
suggests that some level of related diversification is beneficial but that evolving into an unfocused 
enterprise by diversifying into unrelated businesses may destroy value (Christensen and Montgomery, 
1981; Rumelt, 1982; Paelpu, 1985). 
As suggested by Markides and Williamson (1994), the assumption—either explicit or implicit—
of the above stream of literature is “…to equate the benefits of relatedness with the static exploitation of 
economies of scope.” (p. 150). That is, the literature tends to attribute the benefits of related 
diversification to the simple amortization of investments in fixed assets—a positive spillover—rather than 
to complementarities. We note that positive spillovers have been observed at the level of small groups in 
knowledge intensive settings. Boh et al.’s (2007) analysis of productivity in software teams established 
that a group’s average experience with related activities has a greater positive impact on productivity than 
its average experience with a focal activity. This set-up differs from ours in two ways beyond the obvious 
difference in empirical context.  First, it measures the returns to absolute experience rather than to focus. 
Second, it tests for positive spillovers but not for the complementarities that we measure in our study.  
In this study, we present an approach for unpacking the benefits of related diversification by 
determining the extent to which they emerge from either or both of these sources. To achieve this, we first   9
define the “relatedness” of an activity based on the potential for positive spillovers or complementarities 
with a focal activity. Among hospital patients, disease categories that frequently co-occur in patients with 
cardiovascular disease represent areas with the highest such potential. In our setting, positive spillovers 
exist when the level of specialization in related segments (i.e. the share of an operating unit’s activity in 
related segments) impacts performance in the focal segment independent of the unit’s level of 
specialization in the latter. For example, we would predict that a hospital that is more specialized in 
endocrinology would provide better outcomes for cardiovascular patients—regardless of its level of 
specialization in cardiovascular care—as diabetes tends to be a common co-occurring condition for 
cardiovascular patients. Our expectation here is that, in a knowledge-intensive setting such as a hospital 
and because “…repetition, experience and homogeneity of tasks breed competence” (Skinner, 1974), 
greater hospital specialization in endocrinology would produce deeper organizational know-how with 
respect to diabetes.  This know-how could be directly applied to patients hospitalized for cardiovascular 
disease but who also have diabetes. As a result, the benefits of this know-how would accrue to 
cardiovascular patients regardless of how specialized the hospital is in cardiovascular care. This suggests 
the following hypothesis: 
 
Hypothesis 2: Increasing an operating unit’s degree of specialization in related business segments 
improves quality performance in its focal business segment (i.e., specialization in related segments has a 
positive spillover on quality performance in the focal segment). 
 
In comparison to positive spillovers, complementarities suggest the presence of 
interdependencies between focal and related activities (Tanriverdi and Venkatraman, 2005). Schilling et 
al. (2003) provide experimental evidence of complementarities by demonstrating that groups learn a focal 
task at a faster rate when group members are exposed to related (i.e., moderate) variety—as opposed to 
no variety or unrelated (i.e., broad) variety—in tasks over time. They note that, in their experimental 
setting of problem-solving games, groups exposed to variety did not exhibit sub-specialization. That is, 
they did not have one member play all games of one type and another member play all games of another 
type.  In our setting, related diversification typically occurs by having related specialists within the same   10
organization (e.g., cardiologists working in proximity to endocrinologists), not by exposing individuals or 
groups to a range of related activities over time (e.g., individual physicians acting as cardiologist-
endocrinologist combinations). Our study, therefore, examines whether the complementary benefits of 
relatedness identified by Schilling et al. (2003) within individuals or small groups can be extended to 
interactions that tend to occur across specialized individuals or groups. To the extent that 
complementarities exist in our setting, they suggest that some degree of interpersonal or intergroup 
coordination is taking place. 
We test for complementarities across activities by considering whether the benefit of a given level 
of focus depends upon how an operating unit’s non-focal activities are distributed in terms of their 
relatedness to the focal area. As noted earlier, Milgrom and Roberts’ (1994) general definition states that 
two variables are complementary if “the marginal returns to one variable are increasing in the level of the 
other variable” (Milgrom and Roberts, 1994, p. 5). In our setting, the variables are the degree of 
specialization in focal and related non-focal activities, respectively. We expect that if non-focal activities 
are disproportionately allocated to related (rather than unrelated) categories, the marginal benefit of a 
given level of specialization in the focal activity will be greater. In short, we expect that there are returns 
to co-specialization in related activities.  
In the context of our earlier hospital example, complementarities in specialization would imply 
that the benefits of a hospital being relatively specialized in cardiovascular care would be greater if the 
hospital were also specialized in the related area of endocrinology.  These complementarities could be due 
to one or more of several factors. For example, cardiovascular physicians may develop better solutions to 
clinical problems to the extent that they are able to draw on the knowledge of stronger diabetes specialists 
through direct consultation on specific patients.  That is, “co-specialized” hospitals might facilitate formal 
interactions among specialists (e.g., traditional consultations or “grand rounds” (Parrino and White,   11
1990)) or what the medical literature commonly refers to as informal “curbside consultations” (Manian 
and Janssen, 1996; Kuo, et al., 1998; Bergus, et al., 2000).
4  
Beyond direct consultation, hospitals that co-specialize in cardiovascular disease and 
endocrinology may also be more likely to develop clinical centers that focus on the intersection of these 
two clinical areas. That is, such hospitals may direct more cognitive attention (Simon, 1947; Ocasio, 
1997) to this intersection. This point is reflected in the concepts of focused attention (Kahneman, 1973) 
and situated attention (Ross and Nisbett, 1991), which collectively argue that individual behavior and 
social cognition are influenced by an organization’s structures for allocating time, effort, and other 
resources (Ocasio, 1997).  In our setting, one might see a hospital develop a specialized program in 
cardiovascular endocrinology, which would be staffed by physicians and other clinicians (e.g., nurses, 
nutritionists) dedicated to this subspecialty. As this subspecialty expertise develops, one would expect 
cardiovascular specialists in the hospital—either physicians or other clinical staff—to interpret and 
encode more effectively the learning from their own specialized experience (Levitt and March, 1988). In 
line with this logic, we propose the following hypothesis: 
 
Hypothesis 3: Increasing an operating unit’s degree of specialization in related business segments 
increases the marginal benefit (in terms of quality performance) of specialization in the focal business 
segment (i.e., specialization in related segments complements specialization in the focal segment to 
improve quality performance). 
 
To illustrate the predictions of our three hypotheses, we present a simple formalization. Assume 
that a hospital is composed of three types of service lines: a focal service line f (in our case, 
cardiovascular care), related service lines r, and unrelated service lines u. The quality of output in a focal 
service line, qf, can be expressed as: 
           ,   ,                         (1) 
                                                 
4 An example of the content of such a consultation would be the post-operative management of patient glucose 
levels following CABG surgery on a diabetic patient. This is an area where both cardiovascular specialists and 
endocrinology specialists provide input into decisions and where there are nuances related to the intersection of 
these two specialties that are not clearly the domain of either. This example highlights the more general coordination 
challenges resulting from subspecialization in medicine (Gawande, 2009).    12
where xf and xr are the shares of a hospital’s activity dedicated to focal and related services, respectively. 
We note that the remaining portion of a hospital’s activity (i.e., 1-xf-xr) is assumed to be dedicated to 
unrelated services. The matrix Z includes other variables that might affect the quality of output in the 
focal service. Each of our predictions can be expressed as a partial derivative of (1). Hypothesis 1 predicts 
that the quality of output in the focal service is increasing in that service’s share of a hospital’s activity 
(i.e., 
   
   
 0 ). Similarly, Hypothesis 2 predicts the same relationship between focal service quality and 
the share of a hospital’s activity attributed to related services (i.e., 
   
   
 0 ). Finally, Hypothesis 3 
predicts a positive cross-partial derivative of focal-service quality with respect to the shares of both the 
focal service and related services (i.e., 
    
      
 0 ). 
The predictions from Hypotheses 2 and 3 offer an important implication. Given our share-based 
measure of specialization, if 100% of a unit’s activity is dedicated to a focal segment, there would, by 
definition, be no room for related activities. Thus, to the extent that either positive spillovers or 
complementarities exist, they provide a potential explanation for why one might observe decreasing 
benefits to focus within an operating unit.  In short, dedicating resources to a focal activity may be helpful 
to a point but not if doing so prevents an adequate level of investment in related segments that generate 
benefits from either positive spillovers or complementarities. 
 
Setting and Data 
Our analysis considers patients receiving coronary artery bypass graft (CABG) surgery as their 
primary procedure. CABG treats blockages of the coronary arteries and is an open-heart procedure in 
which the patient is placed on a heart-lung machine while the heart is stopped. Access to the heart is 
gained through an incision in the chest, while a blood vessel taken from either the leg or chest is used to 
bypass the arterial blockage. Following surgery, patients typically spend one or two days in the intensive 
care unit and five or six days in total receiving post-operative care in the hospital.    13
We focus on CABG patients for several reasons. First, CABG patients are more homogeneous 
than the entire population of cardiovascular patients. Second, one of the more reliably tracked quality 
measures in hospital discharge data is in-hospital mortality—an outcome that occurs relatively frequently 
in patients receiving CABG surgery compared to other clinical areas. Third, CABG patients account for a 
significant portion of cardiovascular patients and, as a whole, cardiovascular patients are numerous and 
tend to have several “secondary” diagnoses in non-cardiovascular areas. This tendency enables us to 
identify those clinical areas from which spillovers to cardiovascular patients are likely to be greatest.  
  Our empirical analysis draws on hospital discharge data from the Nationwide Inpatient Sample 
(NIS), a database maintained by the Agency for Healthcare Research and Quality (AHRQ). The NIS 
contains patient-level data on hospital stays for approximately 1,000 hospitals in the United States each 
year. These hospitals are sampled from state-level hospital discharge databases and approximate a 20 
percent stratified random sample of acute-care hospitals in the United States. Data in the NIS are reported 
at the level of the patient, and all patients admitted to a sampled hospital are included for the year in 
question. These data include details about the hospital (e.g., urban versus rural location, teaching status 
and region of the country), individual patient demographics, the status of the patient upon discharge from 
the hospital, and the patient’s primary and secondary diagnoses and procedures. We estimate both 
hospital- and patient-level models based on individuals who underwent CABG surgery. 
To develop our sample, we begin with the NIS for the years 1995 through 2004. During this 
period, there were 661,910 discharges at 774 hospitals in the NIS data with a primary procedure of CABG 
surgery. We exclude 996 observations that contain insufficient data. Additionally, to control for factors 
that influence in-hospital mortality and to ensure greater homogeneity and comparability across patients, 
we limit our sample to those patients who had one of three primary diagnoses consistent with a primary 
procedure of CABG: acute myocardial infarction (AMI), acute and chronic ischemic heart disease, and   14
angina pectoris.
5 Of the 661,910 discharges, 16,540 had a primary diagnosis other than the three noted 
above and were, therefore, excluded from our data. 
The number of states included in the NIS varies from 19 in 1995 to 37 in 2004. Given that the 
NIS is a stratified random sample, hospitals do not appear in the NIS every year. Our empirical 
specifications include one-year lags of certain variables, which require hospitals to appear in the data for 
pairs of consecutive years. Therefore, we limit our sample to hospitals performing CABG surgery with at 
least one pair of consecutive years in the NIS. Additionally, we exclude hospitals with very low volumes 
of CABG procedures, following the practice of several public and private reporting organizations by 
limiting our sample to facilities performing at least 30 procedures annually (e.g., Pennsylvania Health 
Care Cost Containment Council, 2007). Following these exclusions, our base sample of discharges 
includes 283,003 patients receiving CABG surgery in 382 hospitals (807 hospital-years) between 1996 
(due to our lagged variables) and 2004. 
 
Dependent Variable 
Our regression models capture quality performance using the dependent variable of in-hospital 
mortality. We note that in-hospital mortality—while a critical measure of quality performance—
represents but one dimension of operational performance in hospitals. Unfortunately, we do not have 
access in our setting to other performance measures, such as cost or longer-term measures of clinical 
quality (e.g., patient quality of life or survival following hospital discharge).  
Due to heterogeneity in patient characteristics, raw mortality rates may be biased measures of 
hospital performance that unfairly penalize (benefit) hospitals with a more- (less-) severe mix of patients. 
We thus estimate the risk-adjusted mortality rate (RAMRjt) for each hospital j in year t using a logistic 
regression. We pool all of the patient-level CABG observations in our database. The outcome variable in 
                                                 
5 This group includes patients with a primary International Classification of Diseases, Clinical Modification (ICD-9-
CM) diagnosis code between 410 and 414. Centers for Disease Control and Prevention (2010) provides a description 
of the ICD-9-CM system.   15
this regression is MORTijt, an indicator that equals one if patient i in hospital j in year t died in the 
hospital, and zero otherwise. The form of this regression is as follows: 
i
i ijt
i ijt βX α
) x 1 pr(MORT 1
) x 1 pr(MORT










      (2)
 
Xi represents a vector of patient-level risk factors, including demographic characteristics of the patient, 
the patient’s primary condition, co-existing conditions, and other procedures performed during the same 
hospitalization that may indicate a higher risk of death. We control for patient gender and age, with an 
interaction term to capture the possibility that the effects of age may differ across gender. We categorize 
the patient’s primary condition by the first three digits of the primary diagnosis code (ICD-9-CM code). 
Additionally, we categorize patients with a primary diagnosis of acute myocardial infarction (AMI), or 
heart attack, by the location of the infarction (e.g., anterior, inferior, right ventricular). We measure co-
existing conditions using the approach of Elixhauser et al. (1998), which captures the presence of 
approximately 30 comorbidities using indicator variables for each.
6 Finally, we include indicators for two 
procedures that, if occurring with CABG, represent complicating factors:  angioplasty prior to CABG and 
valve replacement surgery. Though performed by a cardiologist rather than a cardiac surgeon, angioplasty 
represents a primary treatment for coronary artery disease; if angioplasty is not successful, CABG is often 
used as an alternative. Valve replacement surgery, like CABG, is an open-heart surgical procedure.  
To calculate hospital j’s risk-adjusted mortality rate in year t, RAMRjt, we average the predicted 
values for each patient from (2) for hospital j in year t to create the predicted mortality rate PMRjt. We use 
this value, along with the observed mortality rate OMRjt—defined as the total number of CABG deaths at 
hospital j in year t divided by the total number of CABG patients in the hospital over the same time 
period—to calculate RAMRjt: 
                                                 
6 These conditions include: Congestive Heart Failure, Valvular Disease, Pulmonary Circulation Disorders, 
Hypertension (uncomplicated and complicated), Paralysis, Other Neurological Disorders, Chronic Pulmonary 
disease, Diabetes (uncomplicated and complicated), Hypothyroidism, Renal Failure, Liver Disease, Chronic Peptic 
Ulcer Disease, HIV and AIDS, Lymphoma, Metastatic Cancer, Solid Tumor without Metastasis, Rheumatoid 
Arthritis/Collagen Vascular Disease, Coagulation Deficiency, Obesity, Weight Loss, Fluid and Electrolyte 








        (3)
 
AMR represents the observed mortality rate across all hospitals for the study period and is included simply 
to normalize the risk-adjusted rate. 
 
Independent Variables 
Though our analysis focuses on CABG patients, the NIS includes data on every patient in a 
particular hospital in a given year. This feature allows us to observe a hospital’s focus on a particular 
service area as a continuous variable based on the percentage of its total operational activity occurring in 
that area. We measure a hospital's focus in cardiovascular services (FOCUSjt) as the percentage of 
patients at that hospital in a particular year whose primary diagnosis—the principal reason for 
hospitalization—falls in the area of cardiovascular disease.











        (4)
 
where CARDIOijt is a binary indicator that equals one if patient i discharged from  hospital j in year t had 
a primary diagnosis in cardiovascular disease, and zero otherwise. The denominator njt represents the total 
number of patients—cardiovascular or otherwise—discharged from hospital j during year t. We note that 
cardiovascular disease includes, but is not limited to, patients receiving CABG.  It also includes other 
branches of cardiovascular care, such as diagnostic cardiology, interventional cardiology and angioplasty, 
valve surgery, other forms of treatment for heart failure, and treatments related to cardiac rhythm 
management.  As a continuous, share-based measure, FOCUSjt captures operational specialization in a 
more nuanced manner than studies that measure focus in a discrete way, such as a simple count of the 
number of activities in which the organization participates or binary indicators for whether an 
                                                 
7 We define patients with a primary diagnosis in cardiovascular disease as those with a primary diagnosis in major 
diagnostic category (MDC) 5 (i.e., diseases and disorders of the circulatory system).   17
organization is involved in a particular activity (Bozarth and Edwards, 1997; Hayes and Wheelwright, 
1984; Kekre and Srinivasan, 1990; Suarez and Cusumano, 1996; Villalonga, 2004, Huckman and Zinner, 
2008).  
Beyond testing for returns to an operating unit’s focus on a given business segment, we also aim 
to determine whether the composition of that unit’s other activities affects those returns. Specifically, our 
purpose is to examine whether the impact of focus on quality performance depends on the intensity of 
related services. To define related services, we identify hospital service categories with the greatest 
potential for positive spillovers or complementarities with cardiovascular care. We do this by taking 
advantage of data detailing secondary diagnoses (i.e., conditions that are present but not the primary 
reason for the patient’s hospitalization) for each patient. We assume that the presence of these secondary 
conditions suggests the need for knowledge and experience specific to treating them. The NIS database 
includes information on up to 15 secondary diagnoses for each patient, which allows us to determine—
across our entire sample of cardiovascular patients—the frequency of specific secondary diagnoses. We 
aggregate these secondary diagnoses into service groups using Major Diagnostic Categories (MDCs). 
Each MDC corresponds to a single organ system or disease category. Table 1 summarizes the frequency 
with which other MDCs appear as secondary diagnosis categories in patients with a primary diagnosis in 
cardiovascular disease.  
We define related service categories as those that appear as secondary diagnoses for at least 20% 
of primary cardiovascular patients. The implication is that at least two of every ten cardiovascular patients 
may benefit from access to expertise in these related areas through mechanisms such as knowledge 
sharing (Henderson and Cockburn, 1996) among clinical specialists. Our analysis indicates that four of 
the 24 non-cardiovascular MDCs meet this requirement: MDC 4 (Diseases and disorders of the 
respiratory system), MDC 6 (Diseases and disorders of the digestive system), MDC 10 (Endocrine, 
nutritional and metabolic diseases and disorders), and MDC 11 (Diseases and disorders of the kidney and 
urinary tract).  We define the degree to which hospitals are engaged in related service categories 






njt         (5)
 
RELATEDijt is an indicator equal to one if the primary diagnosis for patient i discharged from hospital j in 
year t is in a service area that is related to cardiovascular care. Again, njt represents the total number of 
patients discharged from hospital j in year t. RELATEDjt thus captures the extent to which a hospital 
concentrates on treating patients whose primary needs fall into those areas that most commonly appear as 
secondary needs for primary cardiovascular patients.  
We recognize that our choice of 20% as a cutoff for including service categories in RELATEDjt 
may seem arbitrary. Accordingly, we investigate the robustness of our results to relaxing this threshold. 
Moreover, in our base specification, RELATEDjt is equivalent to a combination of variables representing 
the share of patients in each of several individual MDCs. To validate our decision to combine these 
categories, we employ factor analysis to determine the degree to which the individual MDCs load onto a 
common factor. Though we do not report the results of this analysis in detail here, we note that they 
suggest that the MDCs above the 20% threshold load onto the same factor, while those below do not.
8  
Though we estimate a version of our model including RELATEDjt as a continuous variable, most 
of our models categorize RELATEDjt into discrete groups to facilitate the interpretation of interaction 
effects. We initially split RELATEDjt at the median for each year, dividing it into 
RELATEDBelowMedianjt and RELATEDAboveMedianjt. To allow additional flexibility in the 
specification of interaction effects, our base model further divides relatedness into three levels 
(RELATED1jt, RELATED2jt, and RELATED3jt), with cutoffs defined at the 33
rd and 66
th percentiles of 
RELATEDjt for each year. Hospitals in the RELATED1 category thus have the lowest level of services that 
are related with cardiovascular care while those in the RELATED3 category have the highest. 
                                                 
8 Factor loadings for MDCs 4, 6, 10, and 11 meet a threshold of 0.70, while those for MDCs 8 and 20 are closer to 
zero. Chronbach’s alpha is 0.70 for the combination of MDCs 4, 6, 10, and 11. The removal of any one of these 
individual MDCs results in a slightly lower alpha.   19
Finally, we include a measure of the total volume of admissions at hospital j in year t, which 
allows us to control for the impact of a hospital's overall volume, or size, on mortality rates. In our 
robustness checks, we also run versions of our model that substitute cardiovascular volume or CABG 
volume for total volume. Table 2 presents summary statistics and correlations for the key variables in our 
analysis. We note that FOCUS and RELATED have a correlation of -0.003. This low correlation suggests 




We estimate the following base model to test for the effects of focus and related service intensity 
on risk-adjusted mortality rates: 
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We include year fixed effects (λt) to control for unobserved factors that may drive the average trend in 
CABG mortality over time. We control for overall hospital size with ln(VOLUME)jt-1 and include Xjt, a 
vector of hospital characteristics including urban versus rural location, teaching status and region of the 
country, to capture hospital-level factors that may be associated with mortality rates.  
We take the natural log of focus to allow for a non-linear relationship between FOCUS and 
RAMR. In doing so, we note that our data include some hospitals with high values of FOCUS (e.g., >70% 
of discharges in cardiovascular care). For these hospitals, a change in FOCUS of, say, five percentage 
points is a less substantial shift (and is likely to have a smaller effect on RAMR) than for a hospital with a 
much lower initial value of FOCUS. To examine robustness, we also estimate versions of our base model 
                                                 
9 Some may find this surprising as both FOCUS and RELATED are calculated by dividing hospital volume in certain 
clinical areas over total hospital volume. Thus, to the extent that FOCUS increases, one might expect RELATED to 
decrease. We note that this is not necessarily the case because hospitals also engage in clinical activities, classified 
as unrelated non-focal activities, that are not captured by either FOCUS or RELATED. In fact, given that the means 
of FOCUS and RELATED sum to roughly 0.40, unrelated non-focal activities account for 60% of hospital activity 
on average.   20
in which FOCUS enters as a linear variable. We note, however, that the R
2 for our models using the log of 
FOCUS are consistently higher than those for otherwise similar models using FOCUS as a linear 
regressor.
10 Finally, we demean our measures of FOCUS to facilitate interpretation of interaction terms. 
 We  lag  FOCUS, RELATED, and VOLUME by one year to reduce concerns about reverse 
causality in the relationship between these variables and hospital performance. We do this because it is 
possible that hospitals with strong cardiovascular performance in one year may experience an increase in 
their cardiovascular focus in subsequent years. To the extent that hospitals gain or lose cardiovascular 
volume (and focus) based on their reputations as “good” or “bad” hospitals—reputations that plausibly 
remain relatively stable over the time period we consider—we aim to control for this potential reverse 
causality by including hospital random effects (αj). To examine the appropriateness of using random 
effects versus fixed effects, researchers generally employ a simple Hausman test. However, our panel data 
are clustered by hospital, a characteristic not permitted by the Hausman test, and thus we must rely on a 
Hausman-like test of fixed versus random effects—a test of overidentifying restrictions—implemented in 
Stata using the xtoverid command (Schaffer and Stillman, 2006). In our case, the xtoverid procedure 
produces a test statistic that is not significant at conventional levels (p=0.203), suggesting that random 
effects are both consistent and efficient. We also report the results of the fixed-effects model for 
comparison. 
To the extent that our random- and fixed-effects models fail to control for any remaining, time-
varying unobservables, we supplement these models by running a reverse regression on our time-series 
data to test directly for the effect of prior mortality performance on focus. For this reverse regression, we 
model the current level of focus as a function of the one-year lag of a hospital’s risk-adjusted mortality 
rate. The results of this analysis are discussed in our robustness section later in the paper. 
  In our base regressions, we interact FOCUS with each of the categories of RELATED to 
determine the degree to which the returns to focus—in terms of mortality performance—depend on the 
                                                 
10 Except where explicitly noted in the remainder of this document, ln(FOCUS) and FOCUS are used 
synonymously.   21
intensity with which hospitals engage in related activities. Given the construction of our variables, the 
estimate of β3 represents the total effect of focus for hospitals in RELATED1, and β4 and β5 represent 
similar total effects for hospitals in RELATED2 and RELATED3, respectively. Based on our hypotheses, 
we expect to find that a greater level of FOCUS leads to lower mortality (i.e., β3<0, β4<0, and β5<0 per 
Hypothesis 1), that a greater level of RELATED leads to lower mortality (i.e., β2< β1<0 per Hypothesis 2), 
and that the marginal effect of FOCUS becomes greater in magnitude as hospitals move from RELATED1 
to RELATED2 to RELATED3 (i.e., β5< β4< β3<0 per Hypothesis 3). Put differently, this final prediction 
suggests that the marginal benefit of focus in terms of quality performance should be increasing in the 
hospital’s level of specialization in related activities. 
 
Results and Discussion  
Base Results 
Table 3 presents estimates for several versions of (6). In Column 1, we examine the average 
effect of focus alone. Column 1 suggests that, on average, focus has a negative effect on risk-adjusted 
mortality, a result that is significant at the 1% level. The estimate implies that a one-standard-deviation 
increase from the mean value of FOCUS results in a reduction in the average mortality rate of 0.4 
percentage points (i.e., a 14% reduction). This translates to an additional life saved for every 250 patients 
treated. A similar estimate is reported in Column 2, where the logarithmic form of RELATED is added to 
the model. These results support the beneficial average impact of focus on performance predicted in 
Hypothesis 1. Column 3 presents the results of a model in which the continuous versions of FOCUS and 
RELATED (both in logarithmic form) are interacted. Both variables have been demeaned to facilitate 
interpretation. We begin by noting that specialization in related activities, in and of itself, does not have a 
statistically significant effect on risk-adjusted mortality. That is, we do not find support for the positive 
spillovers predicted in Hypothesis 2. The estimate on the interaction term in Column 3, however, is in the 
predicted direction and statistically significant at conventional levels, suggesting that the marginal benefit   22
of specializing in cardiovascular care is amplified by greater specialization in related areas. Column 3 
thus provides initial support for the complementarities predicted in Hypothesis 3. 
In Columns 4 and 5, we employ various categorical forms of RELATED—first split at the median 
and then into thirds—interacted with FOCUS. Our results again suggest that the marginal effect of focus 
on mortality depends on the level of relatedness. In Column 4, the estimated coefficient on FOCUS is 
negative (but significant only at the 10% level) for hospitals in the RELATEDBelowMedian category. For 
hospitals in the RELATEDAboveMedian category, however, the estimated coefficient on FOCUS is 
negative and significant at the 1% level. We note that this latter estimate is significantly different from the 
estimate of FOCUS for the RELATEDBelowMedian category at the 1% level. Similarly, in Column 5, the 
estimated effect of FOCUS is negative but insignificant for hospitals in RELATED1 and negative and 
significant for hospitals in RELATED2 and RELATED3. These estimates indicate that a one-standard-
deviation increase from the mean value of FOCUS results in an overall reduction in mortality of 0.71 
percentage points for hospitals in the RELATED2 category and 0.74 percentage points for hospitals in the 
RELATED3 category. These improvements correspond to an additional life saved for approximately every 
135 patients treated. We note that while the estimate on FOCUS for hospitals in RELATED3 is not 
significantly different from that for RELATED2, each of these estimates is significantly different from 
that for RELATED1 at the 5% level. Overall, the results in Table 3 suggest that hospitals with the 
moderate-to-high levels of specialization in related services experience greater returns to focus (in terms 
of quality performance) than those with lower levels of specialization in related services. 
A key implication of these findings is that, in the extreme, hospitals with 100% focus on 
cardiovascular care—which do exist in practice and fall, by definition, into the RELATED1 category—
may experience lower returns to focus than a hospital that maintains a substantial focus on cardiovascular 
care but also offers primary services in related areas. As such, these results provide strong support for 
Hypothesis 3 and suggest the importance of complementarities in explaining the benefits of related 
diversification in this setting.    23
  We acknowledge that any endogeneity in our key explanatory variables may lead to biased 
estimates. As noted earlier, we recognize that hospitals with higher-quality CABG programs may attract 
larger absolute volumes of CABG patients, thereby increasing their level of focus on cardiovascular care. 
Though we believe that the lagging of the focus variable and the inclusion of hospital random effects go a 
long way in addressing potential endogeneity concerns, we are able to directly test for reverse causality 
by running a reverse regression model, with the natural log of a hospital’s current focus as the dependent 
variable and its lagged risk-adjusted mortality rate for CABG as the independent variable. The model 
includes hospital random effects and year fixed effects.
11 If focus is indeed endogenously related to 
performance, we would expect to find a negative and significant relationship between the lagged risk-
adjusted mortality rate and the degree of focus in cardiovascular disease. Though we find that the 
coefficient on RAMR is negative, it does not approach conventional levels of statistical significance 
(p=0.878). We note that a similar result is observed if hospital random effects are replaced by hospital 
fixed effects. These results are encouraging, as they mitigate concern that a hospital’s level of focus is 
endogenously determined by its prior performance. 
 
Robustness 
Our results may be sensitive to the choices we have made in generating our sample, measuring 
our variables of interest, and constructing our base model. We conduct several robustness checks to 
examine the extent of this potential sensitivity. 
First, our base model relies on hospital random effects, an approach supported by our test of over-
identifying restrictions. We do, however, examine the robustness of our results to the inclusion of hospital 
fixed effects (Table 3, Column 6). To ensure sufficient precision in estimating hospital effects, the sample 
for our fixed-effects model includes only facilities with at least three annual observations in the sample. 
                                                 
11 The model is specified as follows, where, as before, αj and λt are hospital and year fixed effects, respectively: 
ln                                       
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The results in Column 6 are consistent with those reported in Column 5 and suggest that our finding of 
greater benefits from focus at higher levels of specialization in related services is robust to using fixed 
effects.
12 
  Second, our definition of related services includes the four MDCs that account for secondary 
diagnoses in at least 20% of cardiovascular patients. To examine alternative definitions of related 
services, we consider the impact of restricting and relaxing this threshold. Specifically, we begin by 
defining RELATED to include only the most frequently occurring secondary MDC (MDC 10) and then 
progressively add the next most frequent MDC, working our way down the list in Table 1. The results of 
these models are presented in Table 4. The model specifications are the same as in (6) except that 
RELATED1, RELATED2, and RELATED3 have been defined using the MDCs specified in each column. 
Column 4 repeats our base results. The results in Columns 1, 2 and 3 suggest that as we make the 
threshold more restrictive, the complementarity we see in our base results continues to hold. Columns 5 
and 6 suggest that as we relax the threshold, we initially see little or no effect on our results when adding 
MDC8 but begin to see complementarity dissipate as we further relax the threshold by adding MDC20. 
Specifically, a test of the difference between the estimates on FOCUS for hospitals in RELATED1, 
RELATED2, and RELATED3 in Column 6 suggests that they are statistically indistinguishable at 
conventional levels. These results are consistent with our predictions, as one would expect 
complementarities from related services to decline as the definition of relatedness is expanded to include 
clinical areas that are progressively less likely to appear as secondary diagnoses for cardiovascular 
patients. 
Though not presented in detail here, we perform a number of additional robustness checks. These 
include: (1) running our base models at the patient-level rather than the hospital-level
13; (2) defining 
                                                 
12 One slight difference in these results is that in Column 5, the impact of FOCUS for RELATED2 and RELATED3 
are significantly different both from zero and from the impact of FOCUS for RELATED1. Yet the impacts of 
FOCUS for RELATED2 and RELATED3 are not significantly different from each other. In Column 6, the impact of 
FOCUS for RELATED3 is significantly different both from zero and from the impact of FOCUS for RELATED1 and 
RELATED2. In addition, the impacts of FOCUS for RELATED1 and RELATED2 are not significantly different from 
each other. In both cases, however, the finding of complementarities in specialization is present.   25
FOCUS at the procedure level (i.e., CABG cases as a share of total hospital volume) rather than the 
disease level (i.e., cardiovascular cases as a share of total hospital volume); (3) controlling for 
cardiovascular volume and CABG volume in place of total hospital volume; (4) including only patients 
who actually have secondary conditions in disease areas defined as RELATED; and (5) limiting the 
sample for our fixed-effects model to those hospitals with at least four (rather than at least three) 
observations in the data to improve the precision in estimating our hospital fixed effects. The results of 
each of these additional analyses are consistent with the results presented in Table 4. A few of these 
checks, however, merit additional discussion. 
We begin by noting that our base models capture total hospital volume as part of two different 
variables: ln(VOLUME) and ln(FOCUS). The coefficient on ln(FOCUS) thus represents the marginal 
impact that variable has on mortality, holding ln(VOLUME) constant. An alternate specification would 
replace ln(FOCUS) with logged cardiovascular volume for the hospital. We do not use this approach for 
several reasons. First, we explicitly want to measure the impact of cardiovascular focus, or specialization, 
rather than absolute cardiovascular volume. Second, there is a high degree of co-movement between the 
logged values of cardiovascular volume and total hospital volume (correlation=0.806), so we are not able 
to observe independent variation in each measure. The same is not true for ln(VOLUME) and ln(FOCUS) 
(correlation=-0.192). Third, this alternate specification constrains the impact of a one-unit increase in 
logged cardiovascular volume to be the same, regardless of the level of logged total hospital volume. 
However, the change in ln(FOCUS) for a one-unit increase in cardiovascular volume would differ 
depending on the level of ln(VOLUME), and we want to capture this difference in testing our hypotheses. 
We also note that our base model considers all CABG patients. However, one might expect the 
complementary effect of specialization in related areas to be particularly beneficial for patients that 
actually have secondary conditions in those areas. We thus run a version of our base model with the 
sample limited to the 83% of all CABG patients who had at least one secondary diagnosis in the four 
                                                                                                                                                             
13 These patient-level models are identical to the model presented in (6), with the exception that they also include the 
patient-level covariates in the vector Xi from the regression used to risk-adjust mortality (see (2)).   26
major diagnostic categories that define RELATED in our base regressions. This analysis produces 




Our paper examines how managers can balance the benefits of focus and diversification within 
individual operating units. We begin by establishing within our setting that operational focus is, on 
average, associated with better quality performance. We then examine the extent to which specialization 
in related activities generates positive spillovers that impact the level of quality performance for a focal 
activity; we find no evidence of such spillovers. Finally, we investigate whether there are 
complementarities in specialization across related areas. We find that hospitals with greater levels of 
specialization in related business segments experience a higher marginal benefit to specialization in a 
focal segment. That is, there are complementarities resulting from co-specialization in focal and related 
segments.  
Our study contributes to the literature on specialization in several ways. First, we find that the 
benefits of related diversification—which have been identified across operating units within firms—also 
exist within operating units.  Like studies conducted at the firm level, our results at the level of the 
operating unit suggest that related activities play an important role in the connection between focus and 
performance. Our findings, however, push this analysis deeper by offering evidence that 
complementarities—not just positive spillovers (e.g., simple economies of scale in shared resources)—
play a role in explaining the benefits of related diversification. These results are robust to changes in the 
level of observation, definition of focus, and designation of related businesses.  
In the context of the hospital industry, our work highlights the need for a broader 
conceptualization of what it means for a hospital to specialize. The model of the single-specialty hospital 
has become increasingly popular in areas such as cardiovascular care, orthopedics, and obstetrics. 
Nevertheless, our findings suggest that single-specialty hospitals—and multi-specialty facilities interested 
in emphasizing a specific clinical service—need to look beyond their focal activity to build strong   27
capabilities in complementary areas. This is consistent with the view that, to deliver value for patients 
with specific diseases, health care organizations should include “all needed specialties and the prevalent 
comorbidities” (Porter and Teisberg, 2007).  
Our study faces several potential limitations, and its results should be interpreted accordingly. 
First, we reiterate the empirical issues regarding specification and potential endogeneity that we have 
addressed with the robustness checks discussed above.  Second, our study is limited to one technology 
(CABG surgery) and one industry, which may limit the generalizability of its findings. Nevertheless, the 
theoretical foundation of this paper has its roots in other industries.  For example, the literature on focus 
has largely centered on manufacturing firms (Hayes and Wheelwright, 1984; Brush and Karnani, 1996; 
Bozarth and Edwards, 1997), while the literature on related diversification includes large samples of firms 
representing a cross-section of industries (Rumelt, 1974; Christensen and Montgomery, 1981; Rumelt, 
1982; Palepu, 1985). 
Third, we consider one measure of performance—quality as captured by risk-adjusted 
mortality—but are not able to consider other important operational metrics, such as cost. As a result, our 
paper cannot speak to the impact of focus on overall value (e.g., cost-adjusted quality). The data used in 
this study do not provide information on costs. What is available is data on hospital charges, which, due 
to the varied discounts offered across hospitals and across services within hospitals, are not representative 
of either actual prices or costs. Despite this limitation, quality—which we are able to study—remains a 
critical component in determining the value of health care provided. Examining the implications of 
related diversification for overall value represents an important topic for future study. 
Fourth, our study considers the impact of focus and related diversification on the execution of an 
organization’s current tasks, not on its innovative performance (i.e., its ability to develop new products or 
services). The work of several authors (e.g., Abernathy and Wayne, 1974; March, 1991; and O’Reilly and 
Tushman, 2004) suggests that focused organizations may face significant challenges with respect to 
innovation. Examining whether our findings translate to innovation-based settings thus represents a 
fruitful avenue for future research.   28
Finally, we define related areas based on the frequency with which cardiovascular patients have 
secondary needs in those areas. We assume that related areas represent those most likely to generate 
positive spillovers or complementarities with cardiovascular care. Unfortunately, our data does not allow 
us to isolate the precise mechanism generating the complementarities we observe in our empirical results. 
For example, we cannot determine whether these complementarities are due to physical proximity of 
related services, direct interactions among physicians in different specialties, or the transfer of 
information by specific individuals who span boundaries (Tushman, 1977; Tushman and Scanlon, 1981) 
across clinical specialties (e.g., nurses working with patients in both focal and related areas). 
Additionally, while interactions among individuals may be important in knowledge-intensive settings like 
health care delivery, other mechanisms may be more important sources of complementarities in other 
environments. Additional work is required to investigate such mechanisms. 
Despite these caveats, our study highlights the potential role of complementarities in enhancing 
the benefits of focus on performance. In so doing, it emphasizes that the benefits of related diversification 
may be derived from sources beyond the simple amortization or sharing of fixed assets. Specifically, our 
findings suggest that the returns to an operating unit specializing in a given line of business may depend 
upon the degree to which the unit “co-specializes” in related activities. Ultimately, these results provide a 
potential explanation for why one might find decreasing returns to focusing an organization on a single 
operating activity (or narrow set of activities), especially when it is possible to invest in other activities 
that complement the organization’s area of concentration.    29
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(N=807)  Mean  SD  Min  Max  RAMR  Focus  Volume  Related 
RAMR  0.028  0.018  0.000  0.244  1      
Focus  0.197  0.088  0.067  0.884 ‐ 0.092  1    
Volume  19,125  10,255  2,490  68,464  0.007 ‐ 0.168  1  







(1)  (2)  (3)  (4)  (5)  (6) 
RAMR  RAMR  RAMR  RAMR  RAMR  RAMR 
Ln(Volume)  ‐0.0041 ‐ 0.0043 ‐ 0.0039  ‐0.0040 ‐ 0.0042  0.0168 
  (0.0035)  (0.0035)  (0.0034)  (0.0033)  (0.0034)  (0.0150) 
Ln(Focus)  ‐0.0116** ‐ 0.0115** ‐ 0.0136**     
  (0.00411)  (0.0044)  (0.0050)     
Ln(Related)   ‐ 0.0046 ‐ 0.0011     
    (0.0036)  (0.0042)     
Ln(Focus)*Ln(Related)     ‐ 0.0145*      
     (0.0072)      
Related(AboveMedian)      0.0010     
      (0.0015)     
Ln(Focus)*Related(BelowMedian)      ‐0.0056†     
      (0.0030)     
Ln(Focus)*Related(AboveMedian)      ‐ 0.0245**     
      (0.0085)     
Related2       0.0002 ‐ 0.0012 
       (0.0015)  (0.0026) 
Related3       ‐0.0015 ‐ 0.0011 
       (0.0021)  (0.0041) 
Ln(Focus)*Related1       ‐0.0042 ‐ 0.0065 
       (0.0032)  (0.0126) 
Ln(Focus)*Related2       ‐0.0200* ‐ 0.0158 
       (0.0086)  (0.0147) 
Ln(Focus)*Related3       ‐0.0210** ‐ 0.0536** 
       (0.0071)  (0.0240) 














Observations  807  807  807  807  807  400 
Number of Hospitals  382  382  382  382  382  103 











  (1)  (2)  (3)  (4)  (5)  (6) 
COEFFICIENT  RAMR  RAMR  RAMR  RAMR  RAMR  RAMR 
Ln(Volume)  ‐0.0041 ‐ 0.0040  ‐0.0043 ‐ 0.0042  ‐0.0034 ‐ 0.0043 
  (0.0033)  (0.0034)  (0.0036)  (0.0034)  (0.0032)  (0.0037) 
Related2  ‐0.0015  0.0001  ‐0.0012  0.0002 ‐ 0.0007  0.0011 
  (0.0015)  (0.0014)  (0.0014)  (0.0015)  (0.0013)  (0.0015) 
Related3  ‐0.0006  0.0020  ‐0.0007 ‐ 0.0015  0.0019 ‐ 0.0004 
  (0.0017)  (0.0019)  (0.0023)  (0.0021)  (0.0028)  (0.0022) 
Ln(Focus)*Related1  ‐0.0058 ‐ 0.0047  ‐0.0086 ‐ 0.0042  ‐0.0053†  ‐0.0085* 
  (0.0032)  (0.0030)  (0.0052)  (0.0032)  (0.0031)  (0.0036) 
Ln(Focus)*Related2  ‐0.0075† ‐ 0.0162†  ‐0.0108* ‐ 0.0200* ‐ 0.0098* ‐ 0.0133 
  (0.0041)  (0.0083)  (0.0047)  (0.0086)  (0.0042)  (0.0082) 
Ln(Focus)*Related3  ‐0.0299** ‐ 0.0221**  ‐0.0198** ‐ 0.0210** ‐ 0.0279* ‐ 0.0166** 
  (0.0100)  (0.0071)  (0.0068)  (0.0071)  (0.0124)  (0.0060) 
MDCs in Related  10  4,10  4,6,10  4,6,10,11  4,6,10,11,8  4,6,10,11,8,20
MDCs Added       8  8, 20 
Observations  807  807  807  807  807  807 
Number of Hospitals  382  382  382  382  382  382 
R‐squared  0.076  0.070  0.056  0.066  0.060  0.056 
 
Robust standard errors are clustered by hospital. 
Regressions include a hospital random effects, year fixed effects, and indicators for the following hospital 
characteristics: urban location, teaching status, and geographic region. 
** p<0.01, * p<0.05, † p<0.10 
 